litlas
ログインアカウント作成

Claude B. Sirlin

1978–2026 年に発表

279
論文数
55,396
被引用数
127
h 指数
267
i10 指数

被引用数

Claude B. Sirlin の年別被引用数1960 年: 被引用 1 件1980 年: 被引用 1 件1984 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 1 件1991 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 6 件1997 年: 被引用 8 件1998 年: 被引用 8 件1999 年: 被引用 10 件2000 年: 被引用 10 件2001 年: 被引用 14 件2002 年: 被引用 11 件2003 年: 被引用 19 件2004 年: 被引用 31 件2005 年: 被引用 32 件2006 年: 被引用 40 件2007 年: 被引用 53 件2008 年: 被引用 92 件2009 年: 被引用 150 件2010 年: 被引用 130 件2011 年: 被引用 206 件2012 年: 被引用 191 件2013 年: 被引用 242 件2014 年: 被引用 255 件2015 年: 被引用 350 件2016 年: 被引用 453 件2017 年: 被引用 547 件2018 年: 被引用 620 件2019 年: 被引用 2,279 件2020 年: 被引用 3,075 件2021 年: 被引用 3,300 件2022 年: 被引用 2,240 件2023 年: 被引用 1,829 件2024 年: 被引用 2,932 件2025 年: 被引用 1,285 件2026 年: 被引用 77 件1961〜1979 年は被引用が無いため表示していません1981〜1983 年は被引用が無いため表示していません1985〜1987 年は被引用が無いため表示していません1992〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,155 件、この内訳の 21.9%中国: 引用元論文 3,108 件、この内訳の 16.4%イタリア: 引用元論文 1,016 件、この内訳の 5.3%イギリス: 引用元論文 936 件、この内訳の 4.9%ドイツ: 引用元論文 915 件、この内訳の 4.8%韓国: 引用元論文 848 件、この内訳の 4.5%日本: 引用元論文 740 件、この内訳の 3.9%フランス: 引用元論文 672 件、この内訳の 3.5%カナダ: 引用元論文 591 件、この内訳の 3.1%スペイン: 引用元論文 463 件、この内訳の 2.4%スイス: 引用元論文 354 件、この内訳の 1.9%オランダ: 引用元論文 333 件、この内訳の 1.8%
0%21.9%その他 25.6%

機関

分野

  • Medicine82.4%
  • Biochemistry, Genetics and Molecular Biology9.7%
  • Chemistry2.3%
  • Engineering1.5%
  • Computer Science1%
  • Immunology and Microbiology0.7%
  • その他2.4%

トピック

  • Liver Disease Diagnosis and Treatment16.9%
  • Hepatocellular Carcinoma Treatment and Prognosis10.3%
  • Liver Disease and Transplantation4.6%
  • Diet, Metabolism, and Disease3.2%
  • Radiomics and Machine Learning in Medical Imaging2.8%
  • Cholangiocarcinoma and Gallbladder Cancer Studies2.6%
  • その他59.6%

共著者

全論文

検索で開く
  1. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

    著者: Jorge A. Marrero, Laura Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michaël Abécassis, Lewis R. Roberts, Julie K. Heimbach - Hepatology 2018 被引用: 4,603

  2. AASLD guidelines for the treatment of hepatocellular carcinoma

    著者: Julie K. Heimbach, Laura Kulik, Richard S. Finn, Claude B. Sirlin, Michaël Abécassis, Lewis R. Roberts, Andrew X. Zhu, M. Hassan Murad, Jorge A. Marrero - Hepatology 2017 被引用: 4,162

  3. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

    著者: Rohit Loomba, Victor Seguritan, Weizhong Li, Tao Long, Niels Klitgord, Archana Bhatt, Parambir S. Dulai, Cyrielle Caussy, Richele Bettencourt, Sarah K. Highlander, Marcus B. Jones, Claude B. Sirlin, Bernd Schnabl, Lauren Brinkac, Nicholas J. Schork, Chi‐Hua Chen, David A. Brenner, William Biggs, Shibu Yooseph, J. Craig Venter, Karen E. Nelson - Cell Metabolism 2017 被引用: 1,097

  4. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease

    著者: Gordon I. Smith, Mahalakshmi Shankaran, Mihoko Yoshino, George G. Schweitzer, Maria Chondronikola, Joseph W. Beals, Adewole L. Okunade, Bruce W. Patterson, Edna Nyangau, Tyler Field, Claude B. Sirlin, Saswata Talukdar, Marc K. Hellerstein, Samuel Klein - Journal of Clinical Investigation 2019 被引用: 728

  5. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients

    著者: Victoria Chernyak, Kathryn J. Fowler, Aya Kamaya, Ania Z. Kielar, Khaled M. Elsayes, Mustafa R. Bashir, Yuko Kono, Richard Kinh Gian, Donald G. Mitchell, Amit G. Singal, An Tang, Claude B. Sirlin - Radiology 2018 被引用: 1,115

  6. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

    著者: Veeral Ajmera, Sandra Cepin, Kaleb Tesfai, Heather Hofflich, Karen Cadman, Scarlett Lopez, Egbert Madamba, Ricki Bettencourt, Lisa Richards, Cynthia Behling, Claude B. Sirlin, Rohit Loomba - Journal of Hepatology 2022 被引用: 296

  7. Nonalcoholic fatty liver disease

    著者: Elizabeth M. Brunt, Vincent Wai‐Sun Wong, Valério Nobili, Christopher P. Day, Silvia Sookoian, Jacquelyn J. Maher, Elisabetta Bugianesi, Claude B. Sirlin, Brent A. Neuschwander‐Tetri, Mary E. Rinella - Nature Reviews Disease Primers 2015 被引用: 841

  8. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

    著者: Charlie C. Park, Phirum Nguyen, Carolyn Hernandez, Ricki Bettencourt, Kimberly Ramirez, Lynda Fortney, Jonathan Hooker, Ethan Sy, Michael T. Savides, Mosab H. Alquiraish, Mark A. Valasek, Emily Rizo, Lisa Richards, David A. Brenner, Claude B. Sirlin, Rohit Loomba - Gastroenterology 2016 被引用: 697

  9. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

    著者: Daniel Q. Huang, Laura Wilson, Cynthia Behling, David E. Kleiner, Kris V. Kowdley, Srinivasan Dasarathy, Maral Amangurbanova, Norah A. Terrault, Anna Mae Diehl, Naga Chalasani, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, James Tonascia, Daniela Allende, Annette Bellar, Jaividhya Dasarathy, Srinivasan Dasarathy, Nicole Welch, Rahul Yerrapothu, Mustafa R. Bashir, Anna Mae Diehl, Cynthia D. Guy, Mariko Kopping, Dawn Piercy, Ayako Suzuki, Naglaa Tawadrou, Naga Chalasani, Mandy Cruz, Oscar W. Cummings, Lisa Garrison, Samer Gawrieh, Niharika Samala, Raj Vuppalanchi, Danielle Carpenter, Theresa Cattoor, Janet Freebersyser, Brent A. Neuschwander‐Tetri, Pannapat Angkanaworakul, Achashman Berihun, Andrew Buysse, Theresa Dorrian, Breanna Gulati, Kris V. Kowdley, Kevin Liu, S Misić, Adam Sohal, J. Vuong, Veeral Ajmera, Cynthia Behling, Rohit Loomba, Egbert Madamba, Michael S. Middleton, Lisa Richards, Seema Singh, Claude B. Sirlin, Ryan M. Gill, Bilal Hameed, Remilekun Awe, Daisy Rios Olvera, Norah A. Terrault, Liyun Yuan, Matthew M. Yeh, Somaya Albhaisi, Amon Asgharpour, Sherry Boyett, Melissa J. Contos, Velimir A. Luketic, Arun J. Sanyal, Jolene Schlosser, Mohammad Shadab Siddiqui, David E. Kleiner, Peggy Adamo, Patricia Belt, Jeanne M. Clark, Jennifer DeSanto, Jill Meinert, Laura Miriel, Emily Mitchell, Carrie Shade, Jacqueline Smith, Michael L. Smith, Alice Sternberg, James Tonascia, Mark L. Van Natta, Annette Wagoner, Laura A. Wilson, Tinsay A. Woreta, Katherine P. Yates, Rohit Loomba - Gastroenterology 2023 被引用: 167

  10. Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology

    著者: Daniel Q. Huang, Amit G. Singal, Fasiha Kanwal, Pietro Lampertico, Marı́a Buti, Claude B. Sirlin, Mindie H. Nguyen, Rohit Loomba - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 178

  11. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis

    著者: Tae Gyu Oh, Susy M. Kim, Cyrielle Caussy, Ting Fu, Jian Guo, Shirin Bassirian, Seema Singh, Egbert Madamba, Ricki Bettencourt, Lisa Richards, Ruth T. Yu, Annette R. Atkins, Tao Huan, David A. Brenner, Claude B. Sirlin, Michael Downes, Ronald M. Evans, Rohit Loomba - Cell Metabolism 2020 被引用: 336

  12. Noninvasive, Quantitative Assessment of Liver Fat by MRI‐PDFF as an Endpoint in NASH Trials

    著者: Cyrielle Caussy, Scott B. Reeder, Claude B. Sirlin, Rohit Loomba - Hepatology 2018 被引用: 560

  13. Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis

    著者: Jonathan G. Stine, Nagambika Munaganuru, Abbey Barnard, Jennifer L. Wang, Kellee Kaulback, Curtis K. Argo, Siddarth Singh, Kathryn J. Fowler, Claude B. Sirlin, Rohit Loomba - Clinical Gastroenterology and Hepatology 2020 被引用: 266

  14. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants

    著者: Cynthia L. Hsu, Cyrielle Caussy, Kento Imajo, Jun Chen, Siddharth Singh, Kellee Kaulback, Minh‐da Le, Jonathan Hooker, Xin Tu, Ricki Bettencourt, Meng Yin, Claude B. Sirlin, Richard L. Ehman, Atsushi Nakajima, Rohit Loomba - Clinical Gastroenterology and Hepatology 2018 被引用: 402

  15. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease

    著者: Jeffrey B. Schwimmer, Jethro S. Johnson, Jorge E. Angeles, Cynthia Behling, Patricia Belt, Ingrid B. Borecki, Craig Bross, Janis Durelle, Nidhi Goyal, Gavin Hamilton, Mary L. Holtz, Joel E. Lavine, Makedonka Mitreva, Kimberly P. Newton, Amy Pan, Pippa Simpson, Claude B. Sirlin, Erica Sodergren, Rahul Tyagi, Katherine P. Yates, George M. Weinstock, Nita H. Salzman - Gastroenterology 2019 被引用: 296

  16. Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis

    著者: Arun J. Sanyal, Sudha S. Shankar, Katherine P. Yates, James A. Bolognese, Erika Daly, Clayton A. Dehn, Brent A. Neuschwander‐Tetri, Kris V. Kowdley, Raj Vuppalanchi, Cynthia Behling, James Tonascia, Anthony E. Samir, Claude B. Sirlin, Sarah P. Sherlock, Kathryn J. Fowler, Helen Heymann, Tania N. Kamphaus, Rohit Loomba, Roberto A. Calle - Nature Medicine 2023 被引用: 114

  17. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease

    著者: Cyrielle Caussy, Anupriya Tripathi, Greg Humphrey, Shirin Bassirian, Seema Singh, Claire Faulkner, Ricki Bettencourt, Emily Rizo, Lisa Richards, Zhenjiang Zech Xu, Michael Downes, Ronald M. Evans, David A. Brenner, Claude B. Sirlin, Rob Knight, Rohit Loomba - Nature Communications 2019 被引用: 335

  18. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage

    著者: Mohammad Shadab Siddiqui, Goro Yamada, Raj Vuppalanchi, Mark L. Van Natta, Rohit Loomba, Cynthia D. Guy, Danielle Brandman, James Tonascia, Naga Chalasani, Brent A. Neuschwander‐Tetri, Arun J. Sanyal, Daniela Allende, Srinivasan Dasarathy, Arthur J. McCullough, Revathi Penumatsa, Jaividhya Dasarathy, Joel E. Lavine, Manal F. Abdelmalek, Mustafa R. Bashir, Stephanie Buie, Anna Mae Diehl, Cynthia D. Guy, Christopher Kigongo, Mariko Kopping, David Malik, Dawn Piercy, Naga Chalasani, Oscar W. Cummings, Samer Gawrieh, Linda Ragozzino, Kumar Sandrasegaran, Raj Vuppalanchi, Elizabeth M. Brunt, Theresa Cattoor, Danielle Carpenter, Janet Freebersyser, Debra King, Jinping Lai, Brent A. Neuschwander‐Tetri, Joan Siegner, Susan L. Stewart, Susan Torretta, Kristina Wriston, Maria Cardona Gonzalez, Jodie Davila, Manan Jhaveri, Kris V. Kowdley, Nizar A. Mukhtar, Erik Ness, Michelle Poitevin, Brook A. Quist, Sherilynn Soo, Brandon Ang, Cynthia Behling, Archana Bhatt, Rohit Loomba, Michael S. Middleton, Claude B. Sirlin, Maheen F. Akhter, Nathan M. Bass, Danielle Brandman, Ryan M. Gill, Bilal Hameed, Jacqueline Maher, Norah A. Terrault, Ashley Ungermann, Matthew M. Yeh, Sherry Boyett, Melissa J. Contos, S. Kirwin, Velimir A. Luketic, Puneet Puri, Arun J. Sanyal, Jolene Schlosser, Mohammad Shadab Siddiqui, Leslie Yost-Schomer, Elizabeth M. Brunt, Kathryn J. Fowler, David E. Kleiner, Edward Doo, Sherry Hall, Jay H. Hoofnagle, Jessica J. Lee, Patricia R. Robuck, Averell H. Sherker, Rebecca Torrance, Patricia Belt, Jeanne M. Clark, J.A. Dodge, Michele Donithan, Erin Hallinan, Milana Isaacson, Mariana Lazo, Jill Meinert, Laura Miriel, Jacqueline Smith, Michael L. Smith, Alice Sternberg, James Tonascia, Mark L. Van Natta ほか 4 名 - Clinical Gastroenterology and Hepatology 2019 被引用: 268

  19. Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis

    著者: Cyrielle Caussy, Mosab H. Alquiraish, Phirum Nguyen, Carolyn Hernandez, Sandra Cepin, Lynda Fortney, Veeral Ajmera, Ricki Bettencourt, Summer Collier, Jonathan Hooker, Ethan Sy, Emily Rizo, Lisa Richards, Claude B. Sirlin, Rohit Loomba - Hepatology 2017 被引用: 372

  20. Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD

    著者: Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, Masato Yoneda, Nancy Sutter, Jinho Jung, Lin Tuo, Xin Tu, Jaclyn Bergstrom, Khang Nguyen, Leyna Nguyen, Tracy Le, Egbert Madamba, Lisa Richards, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajima, Rohit Loomba - Journal of Hepatology 2022 被引用: 100

  21. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study

    著者: Rohit Loomba, Tanya Wolfson, Brandon Ang, Jonathan Hooker, Cynthia Behling, Michael R. Peterson, Mark A. Valasek, Grace Lin, David A. Brenner, Anthony Gamst, Richard L. Ehman, Claude B. Sirlin - Hepatology 2014 被引用: 477

  22. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis

    著者: Jinho Jung, Rohan Loomba, Rohan R Loomba, Kento Imajo, Egbert Madamba, Sanil Gandhi, Ricki Bettencourt, Seema Singh, Carolyn Hernandez, Mark A. Valasek, Cynthia Behling, Lisa Richards, Katie Fowler, Claude B. Sirlin, Atsushi Nakajima, Rohit Loomba, Rohit Loomba - Gut 2020 被引用: 147

  23. Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys

    著者: Jeffrey B. Schwimmer, Patricia Ugalde‐Nicalo, Jean A. Welsh, Jorge E. Angeles, María Cordero, Kathryn E. Harlow, Adina Alazraki, Janis Durelle, Jack Knight‐Scott, Kimberly P. Newton, Rebecca Cleeton, Cynthia Knott, Juna V. Konomi, Michael S. Middleton, Curtis Travers, Claude B. Sirlin, Albert Altés, Ahlia Sekkarie, Courtney McCracken, Miriam B. Vos - JAMA 2019 被引用: 245

  24. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

    著者: Mazen Noureddin, Jessica Lam, Michael R. Peterson, Michael S. Middleton, Gavin Hamilton, Thuy‐Anh Le, Ricki Bettencourt, Chris Changchien, David A. Brenner, Claude B. Sirlin, Rohit Loomba - Hepatology 2013 被引用: 544